glp-1 stomach paralysis class action in louisiana semaglutide ileus legal team pancreatitis vomiting in louisiana Ozempic Lawsuit for Blindness, and Injury Claims louisiana semaglutide gastric intestinal obstruction – louisiana glp-1 vomiting class action

40 :

I see people suffering, people in wheelchairs from strokes, people dying of cancer, from cancer of the uterus something five-fold higher in the obese

and (3) "No, and I do not plan to take them. In total,11.8 percent of adults reported using GLP-1 agonists in 2025, about the same percentage of users reported in 2023 by KFF , suggesting that the overall rates of use in the population have held steady over the past two years

Not FDA-approved for any indication

It feeds good gut bacteria and may help with digestion

This product is also manufactured in a cGMP facility in the USA that follows the highest manufacturing standards